JPWO2023015170A5 - - Google Patents

Info

Publication number
JPWO2023015170A5
JPWO2023015170A5 JP2024506163A JP2024506163A JPWO2023015170A5 JP WO2023015170 A5 JPWO2023015170 A5 JP WO2023015170A5 JP 2024506163 A JP2024506163 A JP 2024506163A JP 2024506163 A JP2024506163 A JP 2024506163A JP WO2023015170 A5 JPWO2023015170 A5 JP WO2023015170A5
Authority
JP
Japan
Prior art keywords
seq
nos
antigen
binding fragment
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506163A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528935A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074409 external-priority patent/WO2023015170A2/en
Publication of JP2024528935A publication Critical patent/JP2024528935A/ja
Publication of JPWO2023015170A5 publication Critical patent/JPWO2023015170A5/ja
Pending legal-status Critical Current

Links

JP2024506163A 2021-08-02 2022-08-02 抗ｃｄ３８抗体、抗ｃｄ３抗体、及び二重特異性抗体、並びにその使用 Pending JP2024528935A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163228195P 2021-08-02 2021-08-02
US63/228,195 2021-08-02
PCT/US2022/074409 WO2023015170A2 (en) 2021-08-02 2022-08-02 Anti-cd38 antibodies, anti-cd3 antibodies, and bispecific antibodies, and uses thereof

Publications (2)

Publication Number Publication Date
JP2024528935A JP2024528935A (ja) 2024-08-01
JPWO2023015170A5 true JPWO2023015170A5 (enrdf_load_stackoverflow) 2025-09-11

Family

ID=83049800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506163A Pending JP2024528935A (ja) 2021-08-02 2022-08-02 抗ｃｄ３８抗体、抗ｃｄ３抗体、及び二重特異性抗体、並びにその使用

Country Status (9)

Country Link
US (1) US20250277051A1 (enrdf_load_stackoverflow)
EP (1) EP4380977A2 (enrdf_load_stackoverflow)
JP (1) JP2024528935A (enrdf_load_stackoverflow)
KR (1) KR20240042009A (enrdf_load_stackoverflow)
CN (1) CN117751144A (enrdf_load_stackoverflow)
AU (1) AU2022323166A1 (enrdf_load_stackoverflow)
CA (1) CA3226428A1 (enrdf_load_stackoverflow)
IL (1) IL310024A (enrdf_load_stackoverflow)
WO (1) WO2023015170A2 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117327186B (zh) * 2023-07-12 2024-03-12 北京达成生物科技有限公司 结合mmp3蛋白的双特异性抗体及其用途
CN119236080A (zh) * 2024-09-29 2025-01-03 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 一种医药组合物在制备用于治疗多发性硬化药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3785186T2 (de) 1986-09-02 1993-07-15 Enzon Lab Inc Bindungsmolekuele mit einzelpolypeptidkette.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0672142B1 (en) 1992-12-04 2001-02-28 Medical Research Council Multivalent and multispecific binding proteins, their manufacture and use
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
AU2005282700A1 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
CN101198698B (zh) 2005-03-31 2014-03-19 中外制药株式会社 通过调节多肽缔合制备多肽的方法
DE102005028778A1 (de) 2005-06-22 2006-12-28 SUNJÜT Deutschland GmbH Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage
EP2035456A1 (en) 2006-06-22 2009-03-18 Novo Nordisk A/S Production of bispecific antibodies
EP2424567B1 (en) 2009-04-27 2018-11-21 OncoMed Pharmaceuticals, Inc. Method for making heteromultimeric molecules
UA118255C2 (uk) * 2012-12-07 2018-12-26 Санофі Композиція, яка містить антитіло до cd38 і леналідомід
KR20230022270A (ko) * 2014-03-28 2023-02-14 젠코어 인코포레이티드 Cd38 및 cd3에 결합하는 이중특이적 항체
US11773166B2 (en) * 2014-11-04 2023-10-03 Ichnos Sciences SA CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production
WO2017081211A2 (en) * 2015-11-10 2017-05-18 University Medical Center Hamburg - Eppendorf Antigen-binding polypeptides directed against cd38
CN117964758A (zh) * 2017-10-10 2024-05-03 赛诺菲 抗cd38抗体及与抗cd3和抗cd28抗体的组合
AU2019367218A1 (en) * 2018-10-26 2021-06-03 TeneoFour, Inc. Heavy chain antibodies binding to CD38
EP3993831A1 (en) * 2019-07-01 2022-05-11 Sorrento Therapeutics, Inc. Heterodimeric antibodies that bind to cd38 and cd3

Similar Documents

Publication Publication Date Title
CN109096401B (zh) 抗Her2纳米抗体及其编码序列和用途
JP2019107018A5 (enrdf_load_stackoverflow)
JPWO2019224711A5 (enrdf_load_stackoverflow)
SI2342234T1 (en) MONOCOLIC ANTI-GT468 CANCER CANCER PROTITEL
BR112021007690A2 (pt) anticorpo anti-cldn18.2 e uso do mesmo
JP2008529497A5 (enrdf_load_stackoverflow)
RU2007133108A (ru) АНТИТЕЛА, СВЯЗЫВАЮЩИЕСЯ С EphA2, И МЕТОДЫ ИХ ИСПОЛЬЗОВАНИЯ
JPWO2019173420A5 (enrdf_load_stackoverflow)
JPWO2019224718A5 (enrdf_load_stackoverflow)
IL310938A (en) Anti-ccr8 antibodies and uses thereof
JPWO2019173291A5 (enrdf_load_stackoverflow)
JP2012502938A5 (enrdf_load_stackoverflow)
JP2010508847A5 (enrdf_load_stackoverflow)
JPWO2019224717A5 (enrdf_load_stackoverflow)
JP2013520984A5 (enrdf_load_stackoverflow)
JP2010509931A5 (enrdf_load_stackoverflow)
JP2023511554A (ja) インテグリンαｖβ８に結合する抗体およびその使用
EP2603527A1 (en) Humanized egfr antibodies
CN117264060A (zh) 抗胞外-5’-核苷酸酶的抗体及其在制备肿瘤药物中的应用
WO2022237666A1 (zh) 一种抗Claudin18.2抗体及其抗体药物偶联物
CN119343378A (zh) 靶向itga2的抗体和包含此抗体的抗体药物缀合物
JPWO2023015170A5 (enrdf_load_stackoverflow)
JPWO2023020621A5 (enrdf_load_stackoverflow)
US11767368B1 (en) Antigen-binding protein and use thereof
CN103417965B (zh) 一种含有抗vegf抗体的药物组合物